Medications - FOI Response Register

Question/s to be answered

1. In the past 3 months, how many patients have received the following treatments (for any disease):

•         Berinert (Human C1-esterase inhibitor)

•         Cinryze (Human C1-esterase inhibitor)

•         Firazyr (Icatibant)

•         Icatibant - any brand except Firazyr

•         Orladeyo (Berotralstat)

•         Ruconest (Recombinant human C1-esterase inhibitor)

•         Takhzyro (Lanadelumab)

•         Garadacimab (Andembry)

Nil for all

2. In the past 3 months how many patients have received the following immunoglobulin treatments (for any disease):

•         Cutaquig

•         Cuvitru

•         Gammagard

•         Gammanorm

•         Hizentra

•         Hyqvia

•         Intratect

•         Iqymune

•         Kiovig <5

•         Privigen <5

•         Octagam

•         Panzyga

•         Subgam

•         Any other normal immunoglobulin

Not applicable

Where we have given <5 answers, this is because NHS Shetland considers that providing more specific information carries a high risk of identifying individuals. As such and in accordance with FOISA s 16(1), NHS Shetland confirms that it holds the information requested but that it is exempt from disclosure under FOISA s 38(1)(b) as read with s 38 (2A) as the information constitutes personal data and disclosure would breach the confidentiality of the data subjects